MedPath

Procainamide Hydrochloride

PROCAINAMIDE HYDROCHLORIDE

Approved
Approval ID

0aac32fa-37b7-5520-e063-6394a90a1fe4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 21, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROCAINAMIDE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7113
Application NumberANDA089069
Product Classification
M
Marketing Category
C73584
G
Generic Name
PROCAINAMIDE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateNovember 21, 2023
FDA Product Classification

INGREDIENTS (6)

METHYLPARABENInactive
Quantity: 1 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
SODIUM METABISULFITEInactive
Quantity: 0.8 mg in 1 mL
Code: 4VON5FNS3C
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
PROCAINAMIDE HYDROCHLORIDEActive
Quantity: 100 mg in 1 mL
Code: SI4064O0LX
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Procainamide Hydrochloride - FDA Drug Approval Details